These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35405621)
1. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. El-Mahdy HA; Sallam AM; Ismail A; Elkhawaga SY; Elrebehy MA; Doghish AS Pathol Res Pract; 2022 May; 233():153886. PubMed ID: 35405621 [TBL] [Abstract][Full Text] [Related]
2. A review of the biological role of miRNAs in prostate cancer suppression and progression. Doghish AS; Ismail A; El-Mahdy HA; Elkady MA; Elrebehy MA; Sallam AM Int J Biol Macromol; 2022 Feb; 197():141-156. PubMed ID: 34968539 [TBL] [Abstract][Full Text] [Related]
3. Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. Ismail A; El-Mahdy HA; Abulsoud AI; Sallam AM; Eldeib MG; Elsakka EGE; Zaki MB; Doghish AS Int J Biol Macromol; 2023 Jan; 224():1541-1565. PubMed ID: 36328268 [TBL] [Abstract][Full Text] [Related]
4. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640 [TBL] [Abstract][Full Text] [Related]
5. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression. Chu R; Mo G; Duan Z; Huang M; Chang J; Li X; Liu P Cell Commun Signal; 2014 Jul; 12():45. PubMed ID: 25012758 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
7. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Hung CH; Chiu YC; Chen CH; Hu TH Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233 [TBL] [Abstract][Full Text] [Related]
10. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway. Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling. Hu Z; Wang P; Lin J; Zheng X; Yang F; Zhang G; Chen D; Xie J; Gao Z; Peng L; Xie C Cell Physiol Biochem; 2018; 51(1):470-486. PubMed ID: 30453289 [TBL] [Abstract][Full Text] [Related]
13. Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma. Toh TB; Lim JJ; Hooi L; Rashid MBMA; Chow EK J Hepatol; 2020 Jan; 72(1):104-118. PubMed ID: 31541681 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway. Li QY; Yang K; Liu FG; Sun XG; Chen L; Xiu H; Liu XS Clin Transl Oncol; 2020 Mar; 22(3):302-310. PubMed ID: 31625123 [TBL] [Abstract][Full Text] [Related]
15. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses. Chauhan P; Pramodh S; Hussain A; Elsori D; Lakhanpal S; Kumar R; Alsaweed M; Iqbal D; Pandey P; Al Othaim A; Khan F Front Cell Dev Biol; 2024; 12():1397945. PubMed ID: 39263322 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866 [TBL] [Abstract][Full Text] [Related]
17. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition. Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Chang RM; Xu JF; Fang F; Yang H; Yang LY Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561 [TBL] [Abstract][Full Text] [Related]
19. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455 [TBL] [Abstract][Full Text] [Related]
20. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]